Arcus Biosciences, Inc. (RCUS)
23.87
+0.13
(+0.55%)
USD |
NYSE |
May 21, 16:00
23.92
+0.04
(+0.19%)
After-Hours: 19:59
Arcus Biosciences Shareholders Equity (Quarterly) : 524.00M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 23.52B |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 997.00M |
| Total Liabilities (Quarterly) | 473.00M |
| Debt to Equity Ratio | 0.2156 |
| Current Ratio | 4.038 |
| Net Debt Paydown Yield | 0.34% |